Skip to main content
News Icon

News categories: Publication

The helicase DHX36 resolves G-quadruplex structures and supports stress response

The helicase DHX36 resolves G-quadruplex structures and supports stress response

DNA and RNA G-quadruplex structures are thermodynamically very stable arrangements of four nucleic acid strands, in which the guanines interact via Hoogsteen base pairing. It has been shown that the formation or resolution of RNA G‑quadruplex structures has severe impacts on diverse cellular processes such as transcription or translation. Interestingly, the formation of G-quadruplex structures in untranslated regions of mRNAs can render these mRNAs translationally inactive. The Paeschke lab characterized the RNA targets of DHX36, a 3′−5′ DEAH-box helicase, and discovered that it performs an important function in resolving G-quadruplex structures in the 5´ and 3' untranslated regions of mRNAs. The deletion of DHX36 resulted in an increased formation of stress granules and the phosphorylation of protein kinase R (PKR), caused by the accumulation of G-quadruplex structures in the cytoplasm. PKR is an important factor for the innate immune system and the integrated stress response. PKR is activated upon phosphorylation, which leads to the shutdown of global protein synthesis. In summary, the Paeschke lab could demonstrate that G-quadruplex structures within mRNAs and the cellular stress response are connected and that this connection is established via DHX36 and PKR.


Publication

https://www.immunosensation.de/research/publications/pubmed/dhx36-prevents-the-accumulation-of-translationally-inactive-mrnas-with-g4-structures-in-untranslated.html


Contact

Prof. Katrin Paeschke

Medical Clinic III

Related news

Prof. Christian Strassburg, Direktor der Klinik für Allgemeine Innere Medizin am UKB, mahnt: „Die Abnehmpille ist nicht einfach nur irgendein Spaßfaktor, um jetzt ein bisschen abzunehmen!“

News categories: Publication

Weight-Loss Pill Instead of Injection: Finally, an Easy Way to Lose Weight?

As of September 1, semaglutide will be available in Germany for the treatment of overweight and obesity in tablet form for the first time. The therapy, previously known primarily as a “weight-loss injection,” can now also be taken orally. The market launch is likely to attract considerable interest – but anyone considering treatment should be aware of one thing first: the tablet is not a way to lose a few kilos, but a prescription medication for the treatment of a chronic disease.
View entry
Prof. Matthias Geyer, - together with Prof. Robert P. Fisher from New York, provides an overview of the current state of research on the transcriptional regulation of cyclin-dependent kinases (CDKs) and the prospects for cancer treatment.

News categories: Publication

A Ray of Hope in the Fight Against Cancer

Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus. This is because this family of enzymes plays a fundamental role in gene expression and cell division. An overview of the current state of research on the transcriptional regulation of CDKs and the prospects for cancer treatment was compiled by Prof. Matthias Geyer of the UKB in collaboration with Prof. Robert P. Fisher and has now been published.
View entry
(from left) Julia Nicke and Dr. Mona Malek Mohammadi have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury.

News categories: Publication

Central Hub for Heart Repair Discovered Bonn study: Heart muscle interaction enables cardiac regeneration in the neonatal heart

Researchers at the University Hospital of Bonn (UKB) and the University of Bonn have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury. The findings could open new avenues for future therapies aimed at repairing damaged adult hearts after heart attacks or chronic cardiovascular disease. The study has now been published in the journal Cell Communication and Signaling (Springer Nature).
View entry

Back to the news overview